These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30653023)

  • 1. Re: Patient Perspectives on Peyronie's Disease: Results of Poststudy Interviews from a Phase 2 Trial of Collagenase Clostridium histolyticum.
    Seftel AD
    J Urol; 2019 Apr; 201(4):649. PubMed ID: 30653023
    [No Abstract]   [Full Text] [Related]  

  • 2. Restoration of Penile Function and Patient Satisfaction with Intralesional Collagenase Clostridium Histolyticum Injection for Peyronie's Disease.
    Ziegelmann MJ; Viers BR; McAlvany KL; Bailey GC; Savage JB; Trost LW
    J Urol; 2016 Apr; 195(4 Pt 1):1051-6. PubMed ID: 26476353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intralesional Collagenase Clostridium histolyticum Causes Meaningful Improvement in Men with Peyronie's Disease: Results of a Multi-Institutional Analysis.
    Hellstrom WJG; Tue Nguyen HM; Alzweri L; Chung A; Virasoro R; Tapscott A; Ziegelmann M; Trost L; Gelbard M
    J Urol; 2019 Apr; 201(4):777-782. PubMed ID: 30672843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comment on "Patient perspectives on Peyronie's disease: results of poststudy interviews from a phase 2 trial of collagenase clostridium histolyticum".
    Yafi FA
    Int J Impot Res; 2019 Jul; 31(4):300. PubMed ID: 30266972
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study.
    Levine LA; Cuzin B; Mark S; Gelbard MK; Jones NA; Liu G; Kaufman GJ; Tursi JP; Ralph DJ
    J Sex Med; 2015 Jan; 12(1):248-58. PubMed ID: 25388099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter: Comparison of Collagenase
    Desouky E; Levine LA
    J Urol; 2024 May; 211(5):708-709. PubMed ID: 38382016
    [No Abstract]   [Full Text] [Related]  

  • 7. Baseline characteristics from an ongoing phase 3 study of collagenase clostridium histolyticum in patients with Peyronie's disease.
    Gelbard M; Hellstrom WJ; McMahon CG; Levine LA; Smith T; Tursi J; Kaufman G; Goldstein I
    J Sex Med; 2013 Nov; 10(11):2822-31. PubMed ID: 24112401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Surgery in Peyronie's Disease Following Intralesional Collagenase Clostridium Histolyticum Injections.
    Bazzi M; Jamil ML; Dabaja AA
    Curr Urol Rep; 2019 Jun; 20(8):42. PubMed ID: 31201571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical correction of persistent Peyronie's disease following collagenase clostridium histolyticum treatment.
    Levine LA; Larsen SM
    J Sex Med; 2015 Jan; 12(1):259-64. PubMed ID: 25345351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: Outcomes of Surgery in Peyronie's Disease following Intralesional Collagenase Clostridium histolyticum Injections.
    Seftel AD
    J Urol; 2020 Jan; 203(1):15. PubMed ID: 31625788
    [No Abstract]   [Full Text] [Related]  

  • 11. [Collagenase clostridium histolyticum for Peyronie's disease: A new minimally invasive and effective treatment].
    Lin HC; Zhang HT; Jiang H
    Zhonghua Nan Ke Xue; 2017 Sep; 23(9):771-775. PubMed ID: 29726655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collagenase Clostridium histolyticum for the Treatment of Peyronie's Disease: The Development of This Novel Pharmacologic Approach.
    Gelbard MK; Chagan L; Tursi JP
    J Sex Med; 2015 Jun; 12(6):1481-9. PubMed ID: 25940867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Peyronie's Disease and Injectable Collagenase Clostridium histolyticum: Safety, Efficacy, and Improvements in Subjective Symptoms.
    Morey AF
    J Urol; 2017 Mar; 197(3 Pt 1):752. PubMed ID: 28208540
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Safety and Effectiveness of Collagenase Clostridium Histolyticum in the Treatment of Peyronie's Disease Using a New Modified Shortened Protocol.
    Seftel AD
    J Urol; 2017 Dec; 198(6):1193. PubMed ID: 29144915
    [No Abstract]   [Full Text] [Related]  

  • 15. Collagenase Clostridium Histolyticum: A Review in Peyronie's Disease.
    Dhillon S
    Drugs; 2015 Aug; 75(12):1405-12. PubMed ID: 26201462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies.
    Gelbard M; Goldstein I; Hellstrom WJ; McMahon CG; Smith T; Tursi J; Jones N; Kaufman GJ; Carson CC
    J Urol; 2013 Jul; 190(1):199-207. PubMed ID: 23376148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient perspectives on Peyronie's disease: results of poststudy interviews from a phase 2 trial of collagenase clostridium histolyticum.
    Kaminetsky J; Gittelman M; Kaufman GJ; Smith TM; Jordan GH
    Int J Impot Res; 2019 Jul; 31(4):263-268. PubMed ID: 30237548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: Impact of the Advent of Collagenase Clostridium histolyticum on the Surgical Management of Peyronie's Disease: A Population-Based Analysis.
    Seftel AD
    J Urol; 2020 Jun; 203(6):1045. PubMed ID: 32186446
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-Term Safety and Curvature Deformity Characterization in Patients Previously Treated with Collagenase clostridium Histolyticum for Peyronie's Disease.
    Goldstein I; Lipshultz LI; McLane M; Hu Y; Xiang Q; Liu G; Vijayan S; Gelbard MK
    J Urol; 2020 Jun; 203(6):1191-1197. PubMed ID: 31922462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: Plaque Calcification: An Important Predictor of Collagenase Clostridium histolyticum Treatment Outcomes for Men with Peyronie's Disease.
    Morey AF
    J Urol; 2019 Jun; 201(6):1046. PubMed ID: 30864933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.